Insterstitial brachytherapy of localised prostate cancer using iodine 125 permanent implants;Curiethérapie interstitielle des cancers localisés de prostate par implants permanents d'iode 125

Cancer/Radiotherapie

Volumn 9, Issue 6-7, 2005, Pages 388-393

  Peiffert, Didier ^a  

^a CENTRE ALEXIS VAUTRIN   (France)

Author keywords

Brachytherapy; Permanent implants; Prostate cancer

Indexed keywords

IODINE 125;

CANCER LOCALIZATION; FOLLOW UP; HUMAN; IMPLANT; INTERSTITIAL RADIATION; MEDICAL ASSESSMENT; MEDICAL SPECIALIST; PATIENT SELECTION; PEROPERATIVE ECHOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATE CARCINOMA; RADIATION DOSE DISTRIBUTION; REVIEW; TEAMWORK; VALIDATION PROCESS;

EID: 28344453220     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2005.09.008     Document Type: Short Survey

References (20)

1. D.C. Beyer, T. Thomas, J. Hilbe, and V. Swenson Relative influence of Gleason score and pretreatment PSA in predicting survival following brachytherapy for prostate cancer Brachytherapy 2 2003 77 84
2. J.C. Blasko, P.D. Grimm, J.E. Sylvester, K.R. Badiozamani, D. Hoak, and W. Cavanagh Palladium-103 brachytherapy for prostate carcinoma Int. J. Radiat. Oncol. Biol. Phys. 46 2000 839 850
3. Buron C, Chauveinc L, Salem N, Peiffert D, Pommier P, Delannes M, et al. An economic evaluation of interstitial brachytherapy, radical prostatectomy and external beam radiotherapy for localized prostate cancer: results during the first year after therapy. Joint Brachytherapy Meeting [Abstract] Radiother. Oncol. 2004;71 suppl.:S36.
4. L. Chauveinc, T. Flam, S. Solignac, J.C. Rosenwald, N. Thiounn, and F. Firmin Les indications de la curieth́rapie de prostate par implantation permanente Cancer Radiother. 6 2002 154 158
5. J.M. Cosset, L. Pinillos-Ashton, and F. Mettler Recommandations de la commission internationale de protection radiologique (CIPR) pour la curieth́rapie de haut d́bit de dose et la curieth́rapie de prostate Cancer Radiother. 8 2004 S50 S55
6. M.J. Dattoli, K.E. Wallner, J.C. Cash, R.E. Ross, J.M. Koval, and R.A. Sorace Palladium-103 brachytherapy for clinical T1/T2 prostate carcinomas Int. J. Radiat. Oncol. Biol. Phys. 39 suppl. 1997 221 [Abstract]
7. P.D. Grimm, J.C. Blasko, J.E. Sylvester, R.M. Meier, and W. Cavanagh Ten year biochemical (prostate-specific antigen) control of prostate cancer with (125) I brachytherapy Int. J. Radiat. Oncol. Biol. Phys. 51 2001 31 40
8. G.S. Lederman, W. Cavanagh, P.S. Albert, R. Israeli, J. Lessing, and M. Savino Retrospective stratification of a consecutive cohort of prostate cancer patients treated with a combined regimen of external-beam radiotherapy and brachytherapy Int. J. Radiat. Oncol. Biol. Phys. 49 2001 1297 1303
9. G.S. Merrick, W.M. Butler, R.W. Galbreath, R.L. Stipetich, L.J. Abel, and J.H. Lief Erectile function after permanent prostate brachytherapy Int. J. Radiat. Oncol. Biol. Phys. 52 2002 893 902
10. P. Pommier, A. Villers, A. Bataillard, D. Brune, B. Fervers, and J.M. Bachaud Standards, options et recommandations pour la curieth́rapie des patients atteints de cancer de la prostate:: efficacit́ et toxicit́ Cancer Radiother. 5 2001 770 786
11. L. Potters, Y. Cao, E. Calugaru, T. Torre, P. Fearn, and X.H. Wang A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy Int. J. Radiat. Oncol. Biol. Phys. 50 2001 605 614
12. L. Potters, T. Torre, P.A. Fearn, S.A. Leibel, and M.W. Kattan Potency after permanent prostate brachytherapy for localized prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 50 2001 1235 1242
13. H. Ragde, A.A. Elgamal, P.B. Snow, J. Brandt, A.A. Bartolucci, and B.S. Nadir Ten year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45:Gy external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma Cancer 83 1998 989 1001
14. H. Ragde, G.L. Grado, and B.S. Nadir Brachytherapy for clinically localized prostate cancer: thirteen year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone Arch. Esp. Urol. 54 2001 739 747
15. R.G. Stock, J. Kao, and N.N. Stone Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer J. Urol. 165 2001 436 439
16. R.G. Stock, N.N. Stone, J. Kao, C. Iannuzzi, and P. Unger The effect of disease and treatment-related factors on biopsy results after prostate brachytherapy: implications for treatment optimization Cancer 89 2000 1829 1834
17. R.G. Stock, N.N. Stone, A. Tabert, C. Iannuzzi, and J.K. DeWyngaert A dose-response study for I-125 prostate implants Int. J. Radiat. Oncol. Biol. Phys. 41 1998 101 108
18. R.G. Stock, N.N. Stone, M.F. Wesson, and J.K. DeWyngaert A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation Int. J. Radiat. Oncol. Biol. Phys. 32 1995 219 225
19. N.N. Stone, R.G. Stock, and P. Unger Prostate biopsy results following real-time I-125 brachytherapy J. Urol. 167 2002 919
20. K. Wallner, J. Roy, and L. Harrison Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma J. Clin. Oncol. 14 1996 449 453